Express Pharma - Page 842 of 1139 - Express Pharma

Lonza Capsugel celebrates 25 years of its category-defining joint health solution: UC-II® undenatured type II collagen

Leiutis marks milestone with CDSCO approval for Synthetic Cannabidiol Oral Solution for mild to moderate anxiety disorders

Express Pharma CPHI

Novartis top Japan executives quit over cancer drug scandal

US FDA finds contaminated drug ingredient at GSK Ireland plant

Venus gets marketing nod from Venezuela for meropenem

Glenmark’s NCE GRC 27864 for chronic inflammatory diseases to take part in human trials

Optel Vision to invest in pharmaceutical manufacturing industries

Actavis acquires Silom Medical Company

Aurobindo completes acquisition of select Western European Businesses of Actavis

Merck Sorono launches global initiative to improve patient outcomes in metastatic colorectal cancer

April 1-15, 2014

PARADIGM-HF trial of Novartis’ LCZ696 for chronic heart failure closes early based on strength of interim results